Progress of maintenance therapy for advanced non-small-cell lung cancer
10.3760/cma.j.issn.1673-422X.2016.02.019
- VernacularTitle:晚期非小细胞肺癌维持治疗进展
- Author:
Zhenping WEN
;
Yaling HAN
- Publication Type:Journal Article
- Keywords:
Carcinoma,non-small-cell lung cancer;
Drug therapy;
Molecular targeted therapy;
Immunotherapy
- From:
Journal of International Oncology
2016;43(2):148-151
- CountryChina
- Language:Chinese
-
Abstract:
The efficacy of the standard first-line chemotherapy regimen for advanced non-small cell lung cancer (NSCLC) has reached a plateau.Study confirmed that chemotherapy drugs and molecular targeted drug maintenance treatment can prolong the survival of patients with advanced NSCLC.Immunotherapy has become a maintenance treatment for advanced NSCLC,and further research is needed to confirm its efficacy.
